Chrome Extension
WeChat Mini Program
Use on ChatGLM

Solving Selectivity Issues in LBAs: Case Study Using Gyrolab to Quantify CB307, a Bispecific Humabody in Human Serum.

Thomas Wilford,Phillip D. Bartlett, Anna Schlag, Lukas Jasaitis,Hardev Pandha,Andrew J. Pierce, Richard Hughes

Bioanalysis(2024)SCI 4区SCI 3区

Resolian | Crescendo Biol Ltd | Univ Surrey

Cited 1|Views3
Abstract
Aim: Endogenous interferents can cause nonselectivity in ligand binding pharmacokinetic assays, leading to inaccurate quantification of drug concentrations. We describe the development of a Gyrolab immunoassay to quantify a new modality, CB307 and discuss strategies implemented to overcome matrix effects and achieve selectivity at the desired sensitivity.Results: Matrix effects were mitigated using strategies including increasing minimum required dilution (MRD) and lower limit of quantification, optimization of antibody orientation, assay buffer and solid phase.Conclusion: The strategies described resulted in a selective method for CB307 in disease state matrix that met bioanalytical method validation (BMV) guidance and is currently used to support clinical pharmacokinetic sample analysis in the first-in-human POTENTIA clinical study (NCT04839991) as a secondary clinical end point.
More
Translated text
Key words
CB307,disease state,Gyrolab,humabody,immunoassay,LBA,matrix effects,MRD,PK,selectivity
求助PDF
上传PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本文针对内源性干扰物导致的非选择性问题,开发了一种基于Gyrolab的免疫分析方法,用于定量分析人血清中的双特异性抗体CB307,并提出了克服基质效应、实现选择性的策略。

方法】:通过提高最低稀释要求(MRD)和定量下限、优化抗体方向、试验缓冲液和固相,减少了基质效应的影响。

实验】:在疾病状态下的人血清中实现了对CB307的选择性定量方法,该方法符合生物分析方法验证(BMV)指导原则,并已在第一人用临床试验POTENTIA(NCT04839991)中作为次要临床终点支持药代动力学样本分析。实验使用的数据集未明确提及。